Clinical management of motility disorders in children

Cheryl E Gariepy1, Hayat Mousa

  • 1Center for Cell and Developmental Biology, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio 43205, USA. Cheryl.Gariepy@NationwideChildrens.org

Insights

This review covers pediatric gastrointestinal motility disorders, including esophageal achalasia and chronic intestinal pseudo-obstruction. It details current clinical evaluation and management strategies for these complex conditions in children.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Motility Disorders
  • Clinical Management

Background:

  • Esophageal and gastrointestinal motility disorders are common in children.
  • These conditions significantly impact pediatric health and require specialized care.
  • A comprehensive understanding of their evaluation and management is crucial.

Purpose of the Study:

  • To review the current clinical evaluation and management of common pediatric esophageal and gastrointestinal motility disorders.
  • To synthesize literature findings and clinical experience from a US pediatric motility center.
  • To provide a guide for healthcare professionals managing these conditions.

Main Methods:

  • Literature review of pediatric gastrointestinal motility disorders.
  • Analysis of clinical experience from a specialized pediatric motility center.
  • Discussion of various specific motility disorders and their management.

Main Results:

  • Detailed discussion of esophageal achalasia, gastroparesis, and chronic intestinal pseudo-obstruction.
  • Exploration of motility issues post-surgery (fundoplication, congenital atresia repair, gastroschisis, intestinal transplantation, Hirschsprung's disease resection).
  • Coverage of chronic functional constipation and motility disorders associated with imperforate anus.

Conclusions:

  • Effective management of pediatric GI motility disorders requires a multidisciplinary approach.
  • Early and accurate diagnosis is key to improving patient outcomes.
  • Continued research and experience sharing are vital for advancing care.

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...